![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 40888 |
FusionGeneSummary for UQCRFS1_ANXA3 |
![]() |
Fusion gene information | Fusion gene name: UQCRFS1_ANXA3 | Fusion gene ID: 40888 | Hgene | Tgene | Gene symbol | UQCRFS1 | ANXA3 | Gene ID | 7386 | 306 |
Gene name | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 | annexin A3 | |
Synonyms | RIP1|RIS1|RISP|UQCR5 | ANX3 | |
Cytomap | 19q12 | 4q21.21 | |
Type of gene | protein-coding | protein-coding | |
Description | cytochrome b-c1 complex subunit Rieske, mitochondrialRieske iron-sulfur proteinRieske protein UQCRFS1complex III subunit 5cytochrome b-c1 complex subunit 5ubiquinol-cytochrome c reductase iron-sulfur subunit | annexin A335-alpha calcimedinAnnexin III (lipocortin III)PAP-IIIannexin III (lipocortin III, 1,2-cyclic-inositol-phosphate phosphodiesterase, placental anticoagulant protein III, calcimedin 35-alpha)annexin-3calcimedin 35-alphainositol 1,2-cyclic p | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | P47985 | P12429 | |
Ensembl transtripts involved in fusion gene | ENST00000304863, | ENST00000264908, ENST00000512884, ENST00000503570, | |
Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 2 X 2 X 2=8 |
# samples | 3 | 2 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: UQCRFS1 [Title/Abstract] AND ANXA3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ANXA3 | GO:0006909 | phagocytosis | 9497492 |
Tgene | ANXA3 | GO:0010595 | positive regulation of endothelial cell migration | 16236264 |
Tgene | ANXA3 | GO:0042742 | defense response to bacterium | 9497492 |
Tgene | ANXA3 | GO:0043312 | neutrophil degranulation | 9550422 |
Tgene | ANXA3 | GO:0045766 | positive regulation of angiogenesis | 16236264 |
Tgene | ANXA3 | GO:0051091 | positive regulation of DNA binding transcription factor activity | 16236264 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BI032173 | UQCRFS1 | chr19 | 29703613 | + | ANXA3 | chr4 | 79502926 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000304863 | ENST00000264908 | UQCRFS1 | chr19 | 29703613 | + | ANXA3 | chr4 | 79502926 | - |
intron-intron | ENST00000304863 | ENST00000512884 | UQCRFS1 | chr19 | 29703613 | + | ANXA3 | chr4 | 79502926 | - |
intron-intron | ENST00000304863 | ENST00000503570 | UQCRFS1 | chr19 | 29703613 | + | ANXA3 | chr4 | 79502926 | - |
Top |
FusionProtFeatures for UQCRFS1_ANXA3 |
![]() |
Hgene | Tgene |
UQCRFS1 | ANXA3 |
Cytochrome b-c1 complex subunit Rieske, mitochondrial:Component of the mitochondrial ubiquinol-cytochrome c reductasecomplex dimer (complex III dimer), which is a respiratory chainthat generates an electrochemical potential coupled to ATPsynthesis (PubMed:28673544). Incorporation of UQCRFS1 is thepenultimate step in complex III assembly (By similarity).{ECO:0000250|UniProtKB:P47985, ECO:0000269|PubMed:28673544}. Cytochrome b-c1 complex subunit 9: Possible component ofthe mitochondrial ubiquinol-cytochrome c reductase complex dimer(complex III dimer), which is a respiratory chain that generatesan electrochemical potential coupled to ATP synthesis(PubMed:28673544). UQCRFS1 undergoes proteolytic processing onceit is incorporated in the complex III dimer, including thisfragment, called subunit 9, which corresponds to the transitpeptide (PubMed:28673544). The proteolytic processing is necessaryfor the correct insertion of UQCRFS1 in the complex III dimer, butthe persistence of UQCRFS1-derived fragments may prevent newlyimported UQCRFS1 to be processed and assembled into complex IIIand is detrimental for the complex III structure and function(PubMed:28673544). It is therefore unsure whether the UQCRFS1fragments, including this fragment, are structural subunits(PubMed:28673544). {ECO:0000269|PubMed:28673544}. | Inhibitor of phospholipase A2, also possesses anti-coagulant properties. Also cleaves the cyclic bond of inositol1,2-cyclic phosphate to form inositol 1-phosphate. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for UQCRFS1_ANXA3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for UQCRFS1_ANXA3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for UQCRFS1_ANXA3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | ANXA3 | P12429 | DB09095 | Difluocortolone | Annexin A3 | small molecule | approved|investigational|withdrawn |
Top |
RelatedDiseases for UQCRFS1_ANXA3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | UQCRFS1 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Tgene | ANXA3 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | ANXA3 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | ANXA3 | C0024141 | Lupus Erythematosus, Systemic | 1 | CTD_human |
Tgene | ANXA3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | ANXA3 | C0919267 | ovarian neoplasm | 1 | CTD_human |